Site Management Organizations Market by Therapeutic Areas, Trial Phases, Clinical Trial Components, Type of Interventions and Key Geographies: Industry Trends and Global Forecasts, 2021-2035

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Site Management Organizations
3.3. Role of Site Management Organizations in Clinical Trials
3.4. Services Offered by Site Management Organizations
3.5. Advantages of One-Stop-Shops
3.6. Concluding Remarks

4. COMPETITIVE LANDSCAPE
4.1. Chapter Overview
4.2. Site Management Organizations: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Service(s) Offered
4.2.5. Analysis by Therapeutic Expertise
4.2.6. Analysis by Geographical Reach

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Site Management Organizations: Company Competitiveness Analysis
5.4.1. Competitiveness Analysis: Site Management Organizations in North America
5.4.1.1. Competitiveness Analysis: Small Companies in North America
5.4.1.2. Competitiveness Analysis: Mid-sized Companies in North America
5.4.1.3. Competitiveness Analysis: Large Companies in North America
5.4.2. Competitiveness Analysis: Site Management Organizations in Europe
5.4.2.1. Competitiveness Analysis: Small Companies in Europe
5.4.2.2. Competitiveness Analysis: Mid-sized Companies in Europe
5.4.2.3. Competitiveness Analysis: Large Companies in Europe
5.4.3. Competitiveness Analysis: Site Management Organizations in Asia-Pacific and Rest of the World
5.4.3.1. Competitiveness Analysis: Small Companies in Asia-Pacific and Rest of the World
5.4.3.2. Competitiveness Analysis: Mid-sized Companies in Asia-Pacific and Rest of the World
5.4.3.3. Competitiveness Analysis: Large Companies in Asia-Pacific and Rest of the World

6. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN NORTH AMERICA
6.1. Chapter Overview
6.2. FOMAT Medical Research
6.2.1. Company Overview
6.2.2. Clinical Trial Site Management Services
6.2.3. Recent Developments and Future Outlook
6.3. Parexel
6.3.1. Company Overview
6.3.2. Clinical Trial Site Management Services
6.3.3. Recent Developments and Future Outlook
6.4. Pharm-Olam
6.4.1. Company Overview
6.4.2. Clinical Trial Site Management Services
6.4.3. Recent Developments and Future Outlook
6.5. Veristat
6.5.1. Company Overview
6.5.2. Clinical Trial Site Management Services
6.5.3. Recent Developments and Future Outlook
6.6. WCCT Global
6.6.1. Company Overview
6.6.2. Clinical Trial Site Management Services
6.6.3. Recent Developments and Future Outlook
6.7. Worldwide Clinical Trials
6.7.1. Company Overview
6.7.2. Clinical Trial Site Management Services
6.7.3. Recent Developments and Future Outlook

7. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN EUROPE
7.1. Chapter Overview
7.2. CROMSOURCE
7.2.1. Company Overview
7.2.2. Clinical Trial Site Management Services
7.2.3. Recent Developments and Future Outlook
7.3. Fidelis Research
7.3.1. Company Overview
7.3.2. Clinical Trial Site Management Services
7.3.3. Recent Developments and Future Outlook
7.4. Scandinavian CRO
7.4.1. Company Overview
7.4.2. Clinical Trial Site Management Services
7.4.3. Recent Developments and Future Outlook
7.5. TFS HealthScience
7.5.1. Company Overview
7.5.2. Clinical Trial Site Management Services
7.5.3. Recent Developments and Future Outlook
7.6. Trialbee
7.6.1. Company Overview
7.6.2. Clinical Trial Site Management Services
7.6.3. Recent Developments and Future Outlook

8. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN ASIA-PACIFIC
8.1. Chapter Overview
8.2. CMIC Group
8.2.1. Company Overview
8.2.2. Clinical Trial Site Management Services
8.2.3. Recent Developments and Future Outlook
8.3. George Clinical
8.3.1. Company Overview
8.3.2. Clinical Trial Site Management Service
8.3.3. Recent Developments and Future Outlook
8.4. Tigermed
8.4.1. Company Overview
8.4.2. Clinical Trial Site Management Services
8.4.3. Recent Developments and Future Outlook
8.5. Veeda Clinical Research
8.5.1. Company Overview
8.5.2. Clinical Trial Site Management Services
8.5.3. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Site Management Organizations: Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Focus Area
9.3.5. Most Active Players: Analysis by Number of Partnerships
9.3.6. Geographical Analysis
9.3.6.1. Region-wise Distribution
9.3.6.2. Country-wise Distribution

10. FUNDING AND INVESTMENT ANALYSIS
10.1. Chapter Overview
10.2. Types of Funding
10.3. Site Management Organizations: Funding and Investment Analysis
10.3.1. Analysis by Year of Investment
10.3.2. Analysis by Amount Invested
10.3.3. Analysis by Type of Funding
10.3.4. Year-wise Analysis by Type of Funding and Amount Invested
10.3.5. Most Active Players: Analysis by Number of Funding Instances
10.3.6. Most Active Investors: Analysis by Number of Funding Instances
10.3.7. Analysis by Type of Investor
10.3.8. Analysis by Geography

11. KEY INSIGHTS FROM CLINICAL TRIAL ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Site Management Organizations: Clinical Trial Key Insights
11.3.1. Analysis by Trial Registration Year
11.3.2. Analysis by Trial Registration Year and Enrolled Patient Population
11.3.3. Analysis by Trial Status
11.3.4. Analysis by Trial Registration Year and Trial Status
11.3.5. Analysis by Trial Phase
11.3.6. Analysis by Trial Phase and Enrolled Patient Population
11.3.7. Analysis by Trial Registration Year and Trial Phase (in term of Number of Clinical Trials)
11.3.8. Analysis by Trial Registration Year and Trial Phase (in terms of Number of Enrolled Patient Population)
11.3.9. Analysis by Type of Sponsor / Collaborator
11.3.10. Geographical Analysis by Number of Clinical Trials
11.3.11. Geographical Analysis by Enrolled Patient Population

12. ANALYSIS OF DEMAND FOR CLINICAL TRIAL PARTICIPANTS
12.1. Chapter Overview
12.2. Methodology and Key Assumptions
12.3. Global Demand for Clinical Trial Participants: Analysis by Enrolled Patient Population
12.3.1. Analysis of Demand by Trial Phase
12.3.2. Analysis of Demand by Therapeutic Area
12.3.3. Geographical Demand by Enrolled Patient Population

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS
13.1. Chapter Overview
13.2. Forecast Methodology and Key Assumptions
13.3. Global Site Management Organizations Market, 2021-2035
13.4. Site Management Organizations Market, 2021 and 2035: Distribution by Therapeutic Area
13.5. Site Management Organizations Market, 2021-2035: Distribution by Trial Phase
13.6. Site Management Organizations Market, 2021-2035: Distribution by Clinical Trial Components
13.7. Site Management Organizations Market, 2021-2035: Distribution by Type of Intervention
13.8. Site Management Organizations Market, 2021 and 2035: Distribution by Region
13.8.1. Site Management Organizations Market, 2021 and 2035: Distribution by Country
13.8.2. Site Management Organizations Market in North America, 2021-2035
13.8.2.1. Site Management Organizations Market in the US, 2021-2035
13.8.2.2. Site Management Organizations Market in Canada, 2021-2035
13.8.2.3. Site Management Organizations Market in Rest of North America, 2021-2035
13.8.3. Site Management Organizations Market in Europe, 2021-2035
13.8.3.1. Site Management Organizations Market in the UK, 2021-2035
13.8.3.2. Site Management Organizations Market in France, 2021-2035
13.8.3.3. Site Management Organizations Market in Germany, 2021-2035
13.8.3.4. Site Management Organizations Market in Spain, 2021-2035
13.8.3.5. Site Management Organizations Market in Italy, 2021-2035
13.8.3.6. Site Management Organizations Market in Rest of Europe, 2021-2035
13.8.4. Site Management Organizations Market in Asia-Pacific, 2021-2035
13.8.4.1. Site Management Organizations Market in China, 2021-2035
13.8.4.2. Site Management Organizations Market in Korea, 2021-2035
13.8.4.3. Site Management Organizations Market in India, 2021-2035
13.8.4.4. Site Management Organizations Market in Australia, 2021-2035
13.8.4.5. Site Management Organizations Market in Japan, 2021-2035
13.8.4.6. Site Management Organizations Market in Israel, 2021-2035
13.8.4.7. Site Management Organizations Market in Rest of Asia-Pacific, 2021-2035
13.8.5. Site Management Organizations Market in Latin America, 2021-2035
13.8.6. Site Management Organizations Market in MENA, 2021-2035
13.8.7. Site Management Organizations Market in Rest of the World, 2021-2035

14. CONCLUDING REMARKS

15. EXECUTIVE INSIGHTS
15.1. Chapter Overview
15.2. GDD Experts
15.2.1. Company Snapshot
15.2.2. Interview Transcript: Vinod Gyanchandani, Country Head-Clinical Operations
15.3. SMO - Dra. Marisa Vico
15.3.1. Company Snapshot
15.3.2. Interview Transcript: Marisa Vico, Medical Director and Operations Manager
15.4. Syncretic Clinical Research Services
15.4.1. Company Snapshot
15.4.2. Interview Transcript: Eugene Winifred, Project Manager

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures
Figure 2.1 Executive Summary: Market Forecast
Figure 2.2 Executive Summary: Overall Market Landscape
Figure 2.3 Executive Summary: Partnerships and Collaborations
Figure 2.4 Executive Summary: Funding and Investments
Figure 2.5 Executive Summary: Clinical Trial Key Insights
Figure 2.6 Executive Summary: Analysis of Demand for Clinical Trial Participants
Figure 3.1 Working Model of Site Management Organizations
Figure 3.2 Services Offered by Site Management Organizations
Figure 4.1 Site Management Organizations: Distribution by Year of Establishment
Figure 4.2 Site Management Organizations: Distribution by Company Size
Figure 4.3 Site Management Organizations: Distribution by Location of Headquarters (Region-wise)
Figure 4.4 Site Management Organizations: Distribution by Location of Headquarters (Country-wise)
Figure 4.5 Site Management Organizations: Distribution by Company Size and Location of Headquarters
Figure 4.6 Site Management Organizations: Distribution by Service(s) Offered
Figure 4.7 Site Management Organizations: Distribution by Location of Headquarters and Service(s) Offered
Figure 4.8 Site Management Organizations: Distribution by Therapeutic Expertise
Figure 4.9 Site Management Organizations: Distribution by Geographical Reach
Figure 5.1 Company Competitiveness Analysis: Small Players in North America
Figure 5.2 Company Competitiveness Analysis: Mid-sized Players in North America
Figure 5.3 Company Competitiveness Analysis: Large Players in North America
Figure 5.4 Company Competitiveness Analysis: Small Players in Europe
Figure 5.5 Company Competitiveness Analysis: Mid-sized Players in Europe
Figure 5.6 Company Competitiveness Analysis: Large Players in Europe
Figure 5.7 Company Competitiveness Analysis: Small Players in Asia-Pacific and Rest of the World
Figure 5.8 Company Competitiveness Analysis: Mid-sized Players in Asia-Pacific and Rest of the World
Figure 5.9 Company Competitiveness Analysis: Large Players in Asia-Pacific and Rest of the World
Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2016-2021
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Year-wise Trend by Type of Partnership
Figure 9.4 Partnerships and Collaborations: Distribution by Type of Partnership, 2016-2018 and 2019-2021
Figure 9.5 Partnerships and Collaborations: Distribution by Focus Area
Figure 9.6 Most Active Players: Distribution by Number of Partnerships
Figure 9.7 Partnerships and Collaborations: Distribution by Region
Figure 9.8 Partnerships and Collaborations: Distribution by Country
Figure 10.1 Funding and Investment Analysis: Cumulative Year-wise Trend, 2015-2021
Figure 10.2 Funding and Investment Analysis: Cumulative Year-wise Trend by Amount Invested, 2015-2021 (USD Million)
Figure 10.3 Funding and Investment Analysis: Distribution by Type of Funding
Figure 10.4 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding (USD Million)
Figure 10.5 Funding and Investment Analysis: Year-wise Distribution by Amount Invested and Type of Funding, 2015-2021 (USD Million)
Figure 10.6 Most Active Players: Distribution by Number of Funding Instances
Figure 10.7 Most Active Investors: Distribution by Number of Funding Instances
Figure 10.8 Funding and Investment Analysis: Distribution by Type of Investor
Figure 10.9 Funding and Investment Analysis: Distribution of Amount Invested by Type of Investor (USD Million)
Figure 10.10 Funding and Investment Analysis: Distribution by Region (Continent-wise)
Figure 10.11 Funding and Investment Analysis: Distribution by Region (Country-wise)
Figure 10.12 Funding and Investment Analysis: Distribution of Amount Invested by Region (Country-wise) (USD Million)
Figure 11.1 Clinical Trial Key Insights: Scope and Methodology
Figure 11.2 Clinical Trial Key Insights: Cumulative Distribution by Trial Registration Year, 2016-2021
Figure 11.3 Clinical Trial Key Insights: Distribution by Trial Registration Year and Enrolled Patient Population, 2016-2021
Figure 11.4 Clinical Trial Key Insights: Distribution by Trial Status
Figure 11.5 Clinical Trial Key Insights: Distribution by Trial Registration Year and Trial Status, 2016-2021
Figure 11.6 Clinical Trial Key Insights: Distribution of Number of Trials by Trial Phase
Figure 11.7 Clinical Trial Key Insights: Distribution of Enrolled Patient Population by Trial Phase
Figure 11.8 Clinical Trial Key Insights: Year-wise Distribution by Number of Trials and Trial Phase, 2016-2021
Figure 11.9 Clinical Trial Key Insights: Year-wise Distribution by Number of Enrolled Patient Population and Trial Phase, 2016-2021
Figure 11.10 Clinical Trial Key Insights: Distribution by Type of Sponsor / Collaborator
Figure 11.11 Clinical Trial Key Insights: Geographical Distribution by Number of Clinical Trials
Figure 11.12 Clinical Trial Key Insights: Geographical Distribution by Enrolled Patient Population
Figure 12.1 Analysis of Demand for Clinical Trial Participants: Scope and Methodology
Figure 12.2 Global Demand for Clinical Trial Participants, 2021-2035 (Million Patients)
Figure 12.3 Global Demand for Clinical Trial Participants, 2021-2035: Distribution by Therapeutic Area (Million Patients)
Figure 12.4 Global Demand for Clinical Trial Participants, 2021-2035: Distribution by Trial Phase (Million Patients)
Figure 12.5 Global Demand for Clinical Trial Participants, 2021: Distribution by Region (Million Patients)
Figure 13.1 Global Site Management Organizations Market, 2021-2035 (USD Billion)
Figure 13.2 Site Management Organizations Market, 2021 and 2035: Distribution by Therapeutic Area (USD Billion)
Figure 13.3 Site Management Organizations Market, 2021-2035: Distribution by Trial Phase (USD Billion)
Figure 13.4 Site Management Organizations Market, 2021: Distribution by Clinical Trial Components (USD Billion)
Figure 13.5 Site Management Organizations Market, 2021-2035: Distribution by Type of Intervention (USD Billion)
Figure 13.6 Site Management Organizations Market, 2021 and 2035: Distribution by Region (USD Billion)
Figure 13.7 Site Management Organizations Market, 2021 and 2035: Distribution by Country (USD Billion)
Figure 13.8 Site Management Organizations Market in North America, 2021-2035 (USD Billion)
Figure 13.9 Site Management Organizations Market in the US, 2021-2035 (USD Billion)
Figure 13.10 Site Management Organizations Market in Canada, 2021-2035 (USD Billion)
Figure 13.11 Site Management Organizations Market in Rest of North America, 2021-2035 (USD Billion)
Figure 13.12 Site Management Organizations Market in Europe, 2021-2035 (USD Billion)
Figure 13.13 Site Management Organizations Market in the UK, 2021-2035 (USD Billion)
Figure 13.14 Site Management Organizations Market in France, 2021-2035 (USD Billion)
Figure 13.15 Site Management Organizations Market in Germany, 2021-2035 (USD Billion)
Figure 13.16 Site Management Organizations Market in Spain, 2021-2035 (USD Billion)
Figure 13.17 Site Management Organizations Market in Italy, 2021-2035 (USD Billion)
Figure 13.18 Site Management Organizations Market in Rest of Europe, 2021-2035 (USD Billion)
Figure 13.19 Site Management Organizations Market in Asia-Pacific, 2021-2035 (USD Billion)
Figure 13.20 Site Management Organizations Market in China, 2021-2035 (USD Billion)
Figure 13.21 Site Management Organizations Market in Korea, 2021-2035 (USD Billion)
Figure 13.22 Site Management Organizations Market in India, 2021-2035 (USD Billion)
Figure 13.23 Site Management Organizations Market in Australia, 2021-2035 (USD Billion)
Figure 13.24 Site Management Organizations Market in Japan, 2021-2035 (USD Billion)
Figure 13.25 Site Management Organizations Market in Israel, 2021-2035 (USD Billion)
Figure 13.26 Site Management Organizations Market in Rest of Asia-Pacific, 2021-2035 (USD Billion)
Figure 13.27 Site Management Organizations Market in Latin America, 2021-2035 (USD Billion)
Figure 13.28 Site Management Organizations Market in MENA, 2021-2035 (USD Billion)
Figure 13.29 Site Management Organizations Market in Rest of the World, 2021-2035 (USD Billion)
Figure 14.1 Concluding Remarks: Overall Market Landscape
Figure 14.2 Concluding Remarks: Partnerships and Collaborations
Figure 14.3 Concluding Remarks: Funding and Investment
Figure 14.4 Concluding Remarks: Clinical Trial Key Insights
Figure 14.5 Concluding Remarks: Analysis of Demand for Clinical Trial Participants
Figure 14.6 Concluding Remarks: Market Forecast

List Of Tables
Table 3.1 Comparison of SMOs and CROs
Table 4.1 List of Site Management Organizations
Table 4.2 Site Management Organizations: Information on Type of Site Management Service(s) offered
Table 4.3 Site Management Organizations: Information on Therapeutic Expertise
Table 6.1 Site Management Organizations: List of Profiled Companies (North America)
Table 6.2 FOMAT Medical Research: Company Snapshot
Table 6.3 FOMAT Medical Research: Clinical Trial Site Management Service Portfolio
Table 6.4 FOMAT Medical Research: Recent Developments and Future Outlook
Table 6.5 Parexel: Company Snapshot
Table 6.6 Parexel: Clinical Trial Site Management Service Portfolio
Table 6.7 Paraxel: Recent Developments and Future Outlook
Table 6.8 Pharm-Olam: Company Snapshot
Table 6.9 Pharm-Olam: Clinical Trial Site Management Service Portfolio
Table 6.10 Pharm-Olam: Recent Developments and Future Outlook
Table 6.11 Veristat: Company Snapshot
Table 6.12 Veristat: Clinical Trial Site Management Service Portfolio
Table 6.13 Veristat: Recent Developments and Future Outlook
Table 6.14 WCCT Global: Company Snapshot
Table 6.15 WCCT Global: Clinical Trial Site Management Service Portfolio
Table 6.16 WCCT Global: Recent Developments and Future Outlook
Table 7.1 Site Management Organizations: List of Profiled Companies (Europe)
Table 7.2 CROMSOURCE: Company Snapshot
Table 7.3 CROMSOURCE: Clinical Trial Site Management Service Portfolio
Table 7.4 CROMSOURCE: Recent Developments and Future Outlook
Table 7.5 FIDELIS RESEARCH: Company Snapshot
Table 7.6 FIDELIS RESEARCH: Clinical Trial Site Management Service Portfolio
Table 7.7 FIDELIS RESEARCH: Recent Developments and Future Outlook
Table 7.8 Scandinavian CRO: Company Snapshot
Table 7.9 Scandinavian CRO: Clinical Trial Site Management Service Portfolio
Table 7.10 Scandinavian CRO: Recent Developments and Future Outlook
Table 7.11 TFS HealthScience: Company Snapshot
Table 7.12 TFS HealthScience: Clinical Trial Site Management Service Portfolio
Table 7.13 TFS HealthScience: Recent Developments and Future Outlook
Table 7.14 Trialbee: Company Snapshot
Table 7.15 Trialbee: Clinical Trial Site Management Service Portfolio
Table 7.16 Trialbee: Recent Developments and Future Outlook
Table 8.1 Site Management Organizations: List of Profiled Companies (Asia-Pacific)
Table 8.2 CMIC Group: Company Snapshot
Table 8.3 CMIC Group: Clinical Trial Site Management Service Portfolio
Table 8.4 CMIC Group: Recent Developments and Future Outlook
Table 8.5 George Clinical: Company Snapshot
Table 8.6 George Clinical: Clinical Trial Site Management Service Portfolio
Table 8.7 George Clinical: Recent Developments and Future Outlook
Table 8.8 Tigermed: Company Snapshot
Table 8.9 Tigermed: Clinical Trial Site Management Service Portfolio
Table 8.10 Tigermed: Recent Developments and Future Outlook
Table 8.11 Veeda Clinical Research: Company Snapshot
Table 8.12 Veeda Clinical Research: Clinical Trial Site Management Service Portfolio
Table 8.13 Veeda Clinical Research: Recent Developments and Future Outlook
Table 9.1 Site Management Organizations: List of Partnerships and Collaborations, 2016-2021
Table 10.1 Site Management Organizations: List of Funding and Investments, 2015-2021
Table 12.1 Global Demand for Clinical Trial Participants: Average Number of Patients Enrolled by Trial Phase
Table 16.1 Site Management Organizations: Distribution by Year of Establishment
Table 16.2 Site Management Organizations: Distribution by Company Size
Table 16.3 Site Management Organizations: Distribution by Location of Headquarters (Region-wise)
Table 16.4 Site Management Organizations: Distribution by Location of Headquarters (Country-wise)
Table 16.5 Site Management Organizations: Distribution by Company Size and Location of Headquarters
Table 16.6 Site Management Organizations: Distribution by Service(s) Offered
Table 16.7 Site Management Organizations: Distribution by Location of Headquarters and Service(s) Offered
Table 16.8 Site Management Organizations: Distribution by Therapeutic Expertise
Table 16.9 Site Management Organizations: Distribution by Geographical Reach
Table 16.10 Partnerships and Collaborations: Cumulative Year-wise Trend, 2016-2021
Table 16.11 Partnerships and Collaborations: Distribution by Type of Partnership
Table 16.12 Partnerships and Collaborations: Year-wise Trend by Type of Partnership
Table 16.13 Partnerships and Collaborations: Distribution by Type of Partnership, 2016-2018 and 2019-2021
Table 16.14 Partnerships and Collaborations: Distribution by Focus Area
Table 16.15 Most Active Players: Distribution by Number of Partnerships
Table 16.16 Partnerships and Collaborations: Distribution by Region
Table 16.17 Partnerships and Collaborations: Distribution by Country
Table 16.18 Funding and Investment Analysis: Cumulative Year-wise Trend, 2015-2021
Table 16.19 Funding and Investment Analysis: Cumulative Year-wise Trend by Amount Invested, 2015-2021 (USD Million)
Table 16.20 Funding and Investment Analysis: Distribution by Type of Funding
Table 16.21 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding (USD Million)
Table 16.22 Funding and Investment Analysis: Year-wise Distribution by Amount Invested and Type of Funding, 2015-2021 (USD Million)
Table 16.23 Most Active Players: Distribution by Number of Funding Instances
Table 16.24 Most Active Investors: Distribution by Number of Funding Instances
Table 16.25 Funding and Investment Analysis: Distribution by Type of Investor
Table 16.26 Funding and Investment Analysis: Distribution of Amount Invested by Type of Investor (USD Million)
Table 16.27 Funding and Investment Analysis: Distribution by Region (Continent-wise)
Table 16.28 Funding and Investment Analysis: Distribution by Region (Country-wise)
Table 10.29 Funding and Investment Analysis: Distribution of Amount Invested by Region (Country-wise) (USD Million)
Table 16.30 Clinical Trial Key Insights: Cumulative Distribution by Trial Registration Year, 2016-2021
Table 16.31 Clinical Trial Key Insights: Distribution by Trial Registration Year and Enrolled Patient Population, 2016-2021
Table 16.32 Clinical Trial Key Insights: Distribution by Trial Status
Table 16.33 Clinical Trial Key Insights: Distribution by Trial Registration Year and Trial Status, 2016-2021
Table 16.34 Clinical Trial Key Insights: Distribution of Number of Trials by Trial Phase
Table 16.35 Clinical Trial Key Insights: Distribution of Enrolled Patient Population by Trial Phase
Table 16.36 Clinical Trial Key Insights: Year-wise Distribution by Number of Trials and Trial Phase, 2016-2021
Table 16.37 Clinical Trial Key Insights: Year-wise Distribution by Number of Enrolled Patient Population and Trial Phase, 2016-2021
Table 16.38 Clinical Trial Key Insights: Distribution by Type of Sponsor / Collaborator
Table 16.39 Clinical Trial Key Insights: Geographical Distribution by Number of Clinical Trials
Table 16.40 Clinical Trial Key Insights: Geographical Distribution by Enrolled Patient Population
Table 16.41 Global Demand for Clinical Trial Participants, 2021-2035 (Million Patients)
Table 16.42 Global Demand for Clinical Trial Participants: Distribution by Therapeutic Area (Million Patients)
Table 16.43 Global Demand for Clinical Trial Participants: Distribution by Trial Phase (Million Patients)
Table 16.44 Global Demand for Clinical Trial Participants: Distribution by Region (Million Patients)
Table 16.45 Global Site Management Organizations Market, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.46 Site Management Organizations Market, 2021 and 2035: Distribution by Therapeutic Area (USD Billion)
Table 16.47 Site Management Organizations Market, 2021-2035: Distribution by Trial Phase (USD Billion)
Table 16.48 Site Management Organizations Market, 2021: Distribution by Clinical Trial Components (USD Billion)
Table 16.49 Site Management Organizations Market, 2021-2035: Distribution by Type of Intervention (USD Billion)
Table 16.50 Site Management Organizations Market, 2021 and 2035: Distribution by Region (USD Billion)
Table 16.51 Site Management Organizations Market, 2021 and 2035: Distribution by Country (USD Billion)
Table 16.52 Site Management Organizations Market in North America, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.53 Site Management Organizations Market in the US, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.54 Site Management Organizations Market in Canada, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.55 Site Management Organizations Market in Rest of North America, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.56 Site Management Organizations Market in Europe, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.57 Site Management Organizations Market in the UK, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.58 Site Management Organizations Market in France, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.59 Site Management Organizations Market in Germany, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.60 Site Management Organizations Market in Spain, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.61 Site Management Organizations Market in Italy, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.62 Site Management Organizations Market in Rest of Europe, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.63 Site Management Organizations Market in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.64 Site Management Organizations Market in China, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.65 Site Management Organizations Market in Korea, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.66 Site Management Organizations Market in India, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.67 Site Management Organizations Market in Australia, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.68 Site Management Organizations Market in Japan, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.69 Site Management Organizations Market in Israel, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.70 Site Management Organizations Market in Rest of Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.71 Site Management Organizations Market in Latin America, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.72 Site Management Organizations Market in MENA, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)
Table 16.73 Site Management Organizations Market in Rest of the World, Conservative, Base and Optimistic Scenarios, 2021-2035 (USD Billion)

• 23andMe
• 3H Medi Solution
• 3S Pharma
• Accel Clinical Services
• Accell Clinical Research
• Accelovance 
• accerise
• Access Clinical Research
• Ace Research
• ACI Clinical
• Acrostar SMO
• ACTG-CRO
• Advanced Clinical
• Aetion 
• Affiliated Clinical Research
• AiCure
• Alpha Oncology Research (AOR)
• Altasciences
• Amadeus Capital Partners
• AmberCRO
• American Liver Foundation
• American Research Associates (ARA)
• AmerisourceBergen 
• Analgesic Solutions
• Andronovo Labs 
• Anteris Bio
• Antev 
• Antidote
• AOBiome Therapeutics
• Apex Medical Research
• APF Research
• ApotheCom
• Apptomics
• Aptitude Health
• Ardent Clinical Research Services
• Asian Eye Institute
• Associated Medical 
• Association of Clinical Research Professionals (ACRP)
• AstraZeneca 
• Atlant Clinical
• Aurum Clinical Research
• AusTrials
• AutoCruitment
• Avacare 
• AXELLE Group
• AXIM Biotechnologies
• BBK Worldwide
• Beijing Aisimo Medical Science and Technology
• Beijing CTSMED
• Beijing EasyTrial MedTech 
• Beijing Global Pharmaceutical Research (Acquired by EPS International)
• Beijing Illness Challenge Foundation (ICF)
• Best Clinical Practice
• Bioclinica
• Biomapas
• Biomedical Advanced Research and Development Authority (BARDA)
• Biomic Lifescience
• Biosite Research
• Box
• BrainStorm Cell Therapeutics
• Briban Invest
• Bridge Clinical Research
• BTC Network
• Cactus Clinical Research
• Calmark 
• Canadian Centre for Clinical Trials (CCCT)
• Cardialysis
• CaringKind
• Caris Life Sciences
• Carpathian Research
• Catalyst Regulatory Services (Acquired by Veristat)
• CCT Research
• Central India Clinical Research Services (CICRS) 
• Centre International de Développement Pharmaceutique (CIDP)
• Chase Medical Research
• ChiG 
• Chrondel 
• Cidara Therapeutics
• Cinven
• Clariness 
• Cliantha Research
• Clin Sol 
• Clinade Clinical Research
• Clinart MENA
• ClinChoice
• ClinEdge 
• Clinerion
• Clinexa Life Sciences
• Clinical Accelerator
• Clinical Development Solutions (CDS)
• Clinical Endpoints 
• Clinical Investigation Centre (University Malaya Medical Centre)
• Clinical Research Fastrack
• Clinical Research Partners
• Clinical Trial Networking (CT-N)
• Clinical Trials Management Solutions (CTMS)
• ClinicalConnection
• Clinipace
• CLINISYD 
• Clinixir
• ClinROtech
• ClinSmart
• Clinsol
• Clinspire Research
• Clintec
• Clintract 
• ClinVax 
• Clinverse
• ClinWin Research Services 
• CLS-Ukraine
• CluePoints
• CMIC Group
• CMX Research
• CNS Pharmaceuticals
• COD Research
• Comac Medical
• COMPASS Pathways
• Compass Research
• Continuum Clinical
• Cosmic Clinical Services
• Credevo 
• Crestline Investors
• CRO Pharmatrendz
• Croissance Clinical Research
• CROMSOURCE 
• CRS Clinical Research Services
• CTC North
• CTI Clinical Trial and Consulting Services 
• CTM
• CX Partners
• Cyclo Therapeutics
• Cytespace 
• DAC Patient Recruitment Services
• Datavant
• DAVA Oncology
• DaVita Clinical Research
• Deep Lens
• Deerfield Management
• DEMEDICA
• Devana Solutions
• DFnet
• Dimension Research
• Direct Biologics
• dMed
• Duke Clinical Research Institute (DCRI) 
• eClinical Solutions
• Edenwell Therapeutics
• EDETEK
• Effectus CTR
• EGeen
• Elligo Health Research
• EMMES
• emovis 
• Empower Capital
• EPS Associates
• EPS International
• EQT
• ERT
• ESTERN Medical 
• Estudios Clínicos Latinoamérica (ECLA)
• Ethicscare Clinical Research Services (ECRS)
• EthosExcel
• Everest Clinical Research
• Evolution Research Group (ERG)
• Experior 
• F2 Ventures
• FARMEPO
• FDAMap
• Febo
• FedDev Ontario
• FHI Clinical
• Fidelis Research
• FOMAT Medical Research
• Foundation Medicine
• Free to Breathe
• Frenova Renal Research
• Fresenius Medical Care
• Gaea
• Gama CRO
• GB Sciences 
• GCP Clinical Studies
• GCP Research
• G CURE Healthcare
• GDD Experts
• Genentech
• General Atlantic
• George Clinical
• GIC
• Global Clinical Trials
• Goldman Sachs Asset Management International (GSAMI)
• Gratisol Labs
• GSK
• GuideStar Research
• Haihe Biopharma 
• Hatteras Venture Partners
• Haxon Life Sciences
• Healing Hands Clinical Research Services (HHCRS)
• HealthVerity
• Horizon Research
• Hospital Alemão Oswaldo Cruz 
• EI Hospital de Especialidades Teodoro Maldonado Carbo
• Hoth Therapeutics 
• hyperCORE International
• I’rom Group
• iCo Therapeutics
• iDD Research Solutions
• IKCON PHARMA
• Illingworth Research Group
• InClin
• Incred CR
• Indian Institute of Clinical Research & Management (IICRM)
• Industrifonden
• Infectious Disease Research Institute (IDRI)
• InformedDNA
• Innoplexus 
• Innovaderm
• Innovate Research
• Insignia Clinical Services (ICS)
• INSPIRE
• Integrity Capital Wealth Management
• Inteliquet
• International Research Networks (IRN)
• Intouch Clinical Research Center 
• Intrinsic Imaging (Acquired by WCG)
• Invicro 
• IPHARMA 
• IQVIA
• ITOCHU
• ITOCHU Technology Ventures
• Johnson Clinical Research
• Juno Research
• Karyopharm Therapeutics
• Klinar CRO
• KlinEra 
• KMR Group
• Komplett Clinical Research (KCR)
• KPS Clinical Services
• KV Clinical Research Services (KVCR)
• Kyung Hee University Hospital 
• LEADS Clinical Research and Bio Services
• Limbix
• Linical Americas
• Link Health
• LITMUS 
• LiveRamp
• LMC Manna Research
• Lyft
• MakroCare
• Marshfield Clinic Research Institute
• Mary Bird Perkins Cancer Center
• Mayo Clinic
• med fusion (Acquired by Quest Diagnostics)
• Medable
• MedAvante-ProPhase (Acquired by WCG)
• MEDEX 
• Median Technologies
• Medicor Research
• Medicus Alliance
• Medicus Health Partners
• Medidata 
• Melanoma Research Alliance
• MENE Health Group
• Merck
• Merck Global Health Innovation Fund (GHI)
• Metrics Champion Consortium (MCC) (Acquired by WCG)
• Mitsui
• MMG
• Molecular Templates
• Montserrat Day Hospitals
• MPM Capital
• MPR Development Group
• MTIP
• Muscular Dystrophy Association (MDA)
• National Cancer Center
• National Institute of Clinical Research (NICR)
• National Taiwan University Hospital (NTUH)
• NeoGenomics
• Newton Clinical Research
• NextPhase Research
• Nomad Life Sciences 
• North Estonia Medical Centre
• Novotech
• nRollmed
• Nucleon Therapeutics
• O4 Research
• Oaxaca Site Management Organization (OSMO)
• Octopus Investments
• Octopus Ventures
• Okogen
• OneOncology
• Optimum CRO
• Ora
• Oracle
• orphan reach
• Orphanos
• Ospedale San Raffaele
• P3 Research
• Panthera
• Parallel 6 (Acquired by PRA Health Sciences)
• Parexel 
• PAS Research
• PatientPoint 
• Peachtree BioResearch Solutions
• Penta ID Innovation
• Pepgra
• Pfizer
• Pharmatech
• Pharm-Olam 
• phaware 
• Physicians Research Group (PRG)
• Plexus Research
• Polaris Biopharma Consulting
• PPC Group
• PPD
• Prabhans Clinical Services
• Praxis
• Precision for Medicine
• Precision Health
• Prime Site
• Prodia 
• Protocol First
• ProTrials Research
• Prudentia 
• Psilera 
• Puerto Rico Consortium for Clinical Investigation (PRCCI)
• Pulse Clinical Research
• Pusan National University Hospital (PNUH)
• PWNHealth
• QAscent Research Solutions
• QPS
• Quad-C Management
• Quanticate 
• Quantime World 
• Quest Diagnostics 
• Quintessential Solutions
• Ravek 
• RealTime Software Solutions
• Red Maple Trials
• RemediumOne 
• Research Trials Group
• RESolutions
• Reumalab
• Revive Therapeutics
• Richmond Behavioral Associates (RBA)
• Rock Springs Capital
• Rutherford Health plc
• S4 Research
• Sabre Partners
• Samahitha Research Solutions
• Sandia Clinical Research
• Sanjeevani 
• Sanofi 
• Santa Maria Gastroenterology
• Scandinavian CRO 
• S-Clinical
• SDS Clinical
• Sequoia Capital
• SGS Life Science Services
• Shanghai Shoujia Medical Clinical Research
• SiChaGi Medical Solutions
• SIGAL SMS
• Signify Health
• SitePartner
• Skin Research Institute of Singapore (SRIS)
• Skylight Health
• Smedvig Capital
• SMO – DRA. MARISA VICO 
• SMO Clinical Research (SMO-India)
• SMO ClinPlus
• SMO UCT
• SMOconnect 
• Smooth Drug Development
• SMO-Pharmina 
• Society for Clinical Research Sites
• Solutions OP
• Somaya Research and Health Services
• SoMex Research & Health Organisation
• Sonic Clinical Trials
• Spectral Medical
• Spectrum Clinical Research
• Spero Oncology (Acquired by Veristat)
• SPRI Ukraine
• Springhill Fund
• SQN Clinical
• Statistics Collaborative
• Superstring Capital
• Surescripts
• Syncretic Clinical Research Services
• Syneos Health
• Syntax 
• Synteract
• Syreon 
• Takeda Pharmaceutical
• Terveystalo
• TFS HealthScience
• Association of Clinical Research Professionals (ACRP)
• The Buffalo-Niagara Clinical Alliance (BNCA)
• The Clinical Trial Company (TCTC) (Acquired by Veristat)
• The Clinic'les
• THREAD
• ThreeWire
• Tigermed
• Tiziana Life Sciences
• Topstone Research
• Total Clinical Trial Management
• Translational Research in Oncology (TRIO)
• Trial Management Group (TMG)
• Trialbee
• TrialSpark
• Trifecta (acquired by WCG)
• TriNetX
• Triumph Research Intelligence (TRI)
• Triumpharma 
• United States Department of Defense (DOD)
• uMotif
• Unicorn Protego Site Management Organization (UP SMO)
• United BioSource (UBC)
• University of Yamanshi 
• Urgent Care Clinical Trials
• Vector Oncology
• Veeda Clinical Research
• Veeva Systems
• VeraSci
• Veristat 
• Vicore Pharma
• Vigilare International
• Viomedo
• Virgo
• Walter and Eliza Hall Institute of Medical Research (WEHI)
• WCCT Global
• WCG
• WCG Avoca
• WCG PharmaSeek
• WindRose Health Investors
• Worldwide Clinical Trials
• WuXi Clinical (a WuXi AppTec Company)
• Xcene Research
• Xylem Clinical Research 
• Zagvo Portal
• Zarta Life
• Zosano Pharma

Methodology